{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:53:55Z","timestamp":1764996835625},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.urology.2007.08.012","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T15:51:33Z","timestamp":1198857093000},"page":"1104-1108","source":"Crossref","is-referenced-by-count":69,"title":["Association Between Androgen-Deprivation Therapy and Incidence of Diabetes Among Males with Prostate Cancer"],"prefix":"10.1016","volume":"70","author":[{"given":"M.J.","family":"Lage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.L.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Markus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2007.08.012_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2741\/1891","article-title":"Prostate cancer epidemiology","volume":"11","author":"Hsing","year":"2006","journal-title":"Frontiers Bioscience"},{"key":"10.1016\/j.urology.2007.08.012_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00019053-200220130-00001","article-title":"The economic costs of early stage prostate cancer","volume":"20","author":"Saigal","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.urology.2007.08.012_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.urolonc.2004.11.006","article-title":"Medical care cost of patients with prostate cancer","volume":"22","author":"Jayadevappa","year":"2005","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2007.08.012_bib5","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1002\/cncr.10532","article-title":"The economic burden of prostate cancer, California 1998","volume":"94","author":"Max","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.08.012_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00002820-200503000-00002","article-title":"Developmental life stage and couples\u2019 experiences with prostate cancer: a review of the literature","volume":"28","author":"Harden","year":"2005","journal-title":"Cancer Nursing"},{"key":"10.1016\/j.urology.2007.08.012_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/156801105774574658","article-title":"Current drug therapy for prostate cancer: an overview","volume":"5","author":"Stewart","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.urology.2007.08.012_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijrobp.2006.04.048","article-title":"Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer","volume":"66","author":"Zeliadt","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2007.08.012_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0090-4295(02)02395-6","article-title":"National comprehensive cancer network guidelines for the management of prostate cancer","volume":"61","author":"Scherr","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.08.012_bib12","first-page":"219","article-title":"The evolving role of androgen deprivation therapy in the management of prostate cancer","volume":"55","author":"Cooperberg","year":"2003","journal-title":"Minerva Urologica E Nefrologica"},{"key":"10.1016\/j.urology.2007.08.012_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2007.08.012_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2006.01.054","article-title":"Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists","volume":"68","author":"Alibhai","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.08.012_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2006.06.006","article-title":"Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review","volume":"60","author":"Alibhai","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urology.2007.08.012_bib16","first-page":"2755","article-title":"The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study","volume":"12","author":"Gray","year":"2005","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2007.08.012_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jc.87.2.599","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1016\/j.urology.2007.08.012_bib18","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.08.012_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0038-1634956","article-title":"Risk adjustment in outcome assessment: the Charlson comorbidity index","volume":"32","author":"D\u2019Hoore","year":"1993","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.urology.2007.08.012_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11936-006-0027-5","article-title":"Obesity, diabetes, and associated risk factors","volume":"8","author":"Al Jaroudi","year":"2006","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.urology.2007.08.012_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2004.05.049","article-title":"Disproportionate increase in prevalence of diabetes among patients with congestive heart failure due to systolic dysfunction","volume":"99","author":"Kamalesh","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.urology.2007.08.012_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","article-title":"Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer","volume":"63","author":"Smith","year":"2004","journal-title":"Adult Urology"},{"key":"10.1016\/j.urology.2007.08.012_bib23","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jc.86.9.4261","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"Smith","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2007.08.012_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/ajcn\/81.3.555","article-title":"Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men","volume":"81","author":"Wang","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.urology.2007.08.012_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer","volume":"91","author":"Smith","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2007.08.012_bib26","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.08.012_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.archger.2006.05.005","article-title":"Cardio-cerebrovascular complications in elderly with diabetes","volume":"44","author":"Motta","year":"2007","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.urology.2007.08.012_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2146\/ajhp050385","article-title":"Managing hypertension in patients with type 2 diabetes mellitus","volume":"63","author":"Dobesh","year":"2006","journal-title":"Am J Health Syst Pharm"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507019838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507019838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T08:03:58Z","timestamp":1557129838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429507019838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0090429507019838"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2007.08.012","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}